Overexpression of vascular endothelial growth factor induces cell transformation in cooperation with fibroblast growth factor 2.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 9053843)

Published in Oncogene on January 30, 1997

Authors

M Guerrin1, E Scotet, F Malecaze, E Houssaint, J Plöuet

Author Affiliations

1: Laboratoire de Biologie Moléculaire Eucaryote, UPR 9006 Centre National de la Recherche Scientifique, Toulouse, France.

Articles citing this

Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol (1999) 2.64

Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA. Mol Cell Biol (1998) 2.59

Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. J Virol (2001) 1.09

Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol (2000) 1.01

Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype. Am J Pathol (1997) 0.92

Chemotaxis of MDCK-F cells toward fibroblast growth factor-2 depends on transient receptor potential canonical channel 1. Pflugers Arch (2010) 0.84

Activation of cell migration with fibroblast growth factor-2 requires calcium-sensitive potassium channels. Pflugers Arch (2008) 0.81

The related transcriptional enhancer factor-1 isoform, TEAD4(216), can repress vascular endothelial growth factor expression in mammalian cells. PLoS One (2012) 0.75

Articles by these authors

The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur J Immunol (1999) 2.02

T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med (1996) 1.80

Differentiation of the mouse hepatic primordium. I. An analysis of tissue interactions in hepatocyte differentiation. Cell Differ (1980) 1.57

CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. J Virol (2005) 1.49

A genome wide scan for familial high myopia suggests a novel locus on chromosome 7q36. J Med Genet (2002) 1.48

OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet (2004) 1.42

Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor. Oncogene (1991) 1.40

Differentiation of the mouse hepatic primordium. II. Extrinsic origin of the haemopoietic cell line. Cell Differ (1981) 1.37

Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur J Immunol (1999) 1.36

Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci (1994) 1.31

A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening. Eur J Immunol (2000) 1.17

Origin of hemopoietic stem cells in embryonic bursa of Fabricius and bone marrow studied through interspecific chimeras. Proc Natl Acad Sci U S A (1975) 1.11

Identification of a new locus for isolated familial keratoconus at 2p24. J Med Genet (2005) 1.10

Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol (1995) 1.10

Structural and ultrastructural changes in the developmental process of premature infants' and children's corneas. Cornea (1994) 1.07

Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes. Arthritis Res (2000) 1.04

Investigations on cell lineage and tissue interactions in the developing bursa of Fabricius through interspecific chimeras. Dev Biol (1976) 1.03

Split tolerance induced by chick embryo thymic epithelium allografted to embryonic recipients. J Immunol (1986) 1.01

Confirmation of RAX gene involvement in human anophthalmia. Clin Genet (2008) 1.01

Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J Immunol (2001) 1.00

Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP). Clin Exp Immunol (2002) 0.99

The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific. Biochim Biophys Acta (1995) 0.98

G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells. FEBS Lett (1998) 0.97

Visual outcome after paediatric cataract surgery: is age a major factor? Br J Ophthalmol (1998) 0.96

A chicken leukocyte common antigen: biochemical characterization and ontogenetic study. Eur J Immunol (1987) 0.95

Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes. Invest Ophthalmol Vis Sci (1998) 0.94

Lymphoid stem cell homing to the early thymic primordium of the avian embryo. Eur J Immunol (1980) 0.94

Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. J Immunol (1997) 0.94

A prospective randomized trial of topical soluble 0.1% indomethacin versus 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy. Ophthalmic Surg Lasers (1998) 0.94

Autocrine regulation of bovine retinal capillary endothelial cell (BREC) proliferation by BREC-derived basic fibroblast growth factor. Exp Eye Res (1989) 0.93

Giant retinal tears. Surgical techniques and results using perfluorodecalin and silicone oil tamponade. Retina (1992) 0.93

Epstein-Barr virus and rheumatoid arthritis. Rev Rhum Engl Ed (1998) 0.90

EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones. J Immunol (1999) 0.89

Immunodominant CD8 T cell response to Epstein-Barr virus. Biomed Pharmacother (2001) 0.89

Familial high myopia: evidence of an autosomal dominant mode of inheritance and genetic heterogeneity. Ann Genet (1999) 0.88

Ontogenic restriction of colonization of the bursa of Fabricius. Eur J Immunol (1983) 0.88

Overexpression of the myristoylated alanine-rich C kinase substrate in human choroidal melanoma cells affects cell proliferation. Cancer Res (1998) 0.88

Tissue distribution and ontogenic appearance of a chicken T lymphocyte differentiation marker. Eur J Immunol (1985) 0.86

Frequent recognition of BCRF1, a late lytic cycle protein of Epstein-Barr virus, in the HLA-B*2705 context: evidence for a TAP-independent processing. Eur J Immunol (2001) 0.86

Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2. Oncogene (1998) 0.85

Matrix metalloproteinase 14 overexpression reduces corneal scarring. Gene Ther (2010) 0.85

HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR. Immunogenetics (1993) 0.84

Cell lineage segregation during bursa of Fabricius ontogeny. J Immunol (1987) 0.84

[Corneal collagen cross-linking with ultraviolet-A light and riboflavin for the treatment of progressive keratoconus]. J Fr Ophtalmol (2009) 0.83

[Deep anterior lamellar keratoplasty in the surgical treatment of keratoconus. A 1-year follow-up]. J Fr Ophtalmol (2006) 0.83

[Predictive factors for successful Ferrara intracorneal ring segment implantation in keratoconus]. J Fr Ophtalmol (2011) 0.83

[Diagnosis of ocular toxoplasmosis with the immunoenzyme ELISA technique]. Ophtalmologie (1991) 0.83

Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification. Curr Eye Res (1999) 0.82

Opposing effects of basic fibroblast growth factor and transforming growth factor-beta on the proliferation of cultured bovine retinal capillary endothelial (BREC) cells. Exp Eye Res (1989) 0.81

Implication of stem cell factor in the proliferation of choroidal melanocytes. Exp Eye Res (2001) 0.81

The major myristoylated PKC substrate (MARCKS) is involved in cell spreading, tyrosine phosphorylation of paxillin, and focal contact formation. FEBS Lett (1997) 0.81

Novel B3GALTL mutation in Peters-plus Syndrome. Clin Genet (2009) 0.80

Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group. Br J Ophthalmol (2000) 0.80

[Reversibility of the morphological and functional dedifferentiation occurring in cultures of avian embryonic liver cells (author's transl)]. J Embryol Exp Morphol (1976) 0.80

[Role of the mesoderm in the induction of the synthesis of glycogen during differentiation of the hepatic endoderm]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.79

Confocal biomicroscopy of corneal intraepithelial neoplasia regression following interferon alpha 2b treatment. Br J Ophthalmol (2010) 0.79

Ontogeny of the avian thymus and bursa of Fabricius studied in interspecific chimeras. Ann Immunol (Paris) (1977) 0.79

Differentiation of the primary lymphoid organs in avian embryos: origin and homing of the lymphoid stem cells. Adv Exp Med Biol (1977) 0.79

The T cell repertoire selected in vitro against EBV: diversity, specificity, and improved purification through early IL-2 receptor alpha-chain (CD25)-positive selection. J Immunol (2000) 0.79

[Use of perfluorodecalin during vitrectomy in diabetics]. J Fr Ophtalmol (1993) 0.79

B cell precursors in chick embryos surgically bursectomized at 72 h of incubation. Eur J Immunol (1988) 0.78

The evolution of ocular toxoplasmosis in anti-interferon gamma treated mice. Curr Eye Res (1996) 0.78

Assignment by in situ hybridization of a fibroblast growth factor receptor gene to human chromosome band 10q26. Hum Genet (1991) 0.78

Ocular dominance columns in the adult New World Monkey Callithrix jacchus. Vis Neurosci (2001) 0.78

[Keratoconus]. J Fr Ophtalmol (2013) 0.77

The bursal microenvironment: phenotypic characterization of the epithelial component of the bursa of Fabricius with the use of monoclonal antibodies. Immunology (1986) 0.77

Tissue distribution and appearance in ontogeny of alpha/beta T cell receptor (TCR2) in chicken. Cell Immunol (1990) 0.77

Regulation by transforming growth factor-beta 1 of G1 cyclin-dependent kinases in human retinal epithelial cells. Exp Eye Res (1999) 0.77

Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors. Invest Ophthalmol Vis Sci (2000) 0.76

[Corneal allograft rejection after Descemet stripping automated endothelial keratoplasty (DSAEK): report of three cases]. J Fr Ophtalmol (2009) 0.76

[Extracapsular cataract extraction and implantation in the capsular sac during vitrectomy in diabetics]. J Fr Ophtalmol (1991) 0.76

Identification of a gp100 epitope recognized by HLA-A3 restricted melanoma infiltrating lymphocytes. Int J Oncol (1997) 0.76

Pediatric cataract, myopic astigmatism, familial exudative vitreoretinopathy and primary open-angle glaucoma co-segregating in a family. Mol Vis (2011) 0.76

Endothelin 1 is a growth factor for corneal endothelium. Exp Eye Res (1993) 0.76

[Treatment of traumatic recurrent hyphema with sodium hyaluronate]. Bull Soc Ophtalmol Fr (1987) 0.76

Immunological analysis of the aqueous humour in candida endophthalmitis. II: Clinical study. Br J Ophthalmol (1988) 0.75

Inhibition of intraocular fibrin formation with annexin V. Br J Ophthalmol (1992) 0.75

[Refractive efficacy and tolerance of the foldable phakic iris-supported Artiflex lens in the surgical correction of moderately high myopia: a 2-year follow-up]. J Fr Ophtalmol (2007) 0.75

[Ultrastructural study of the photoreceptors of the human retina during aging]. Bull Assoc Anat (Nancy) (1983) 0.75

[The hypotonia-uveitis-ciliochoroidal detachment syndrome]. Bull Soc Ophtalmol Fr (1983) 0.75

[Anterior radial keratotomy. Experimental study in the surgery of astigmatism]. Bull Soc Ophtalmol Fr (1985) 0.75

[Juvenile xanthogranuloma of the corneoscleral limbus]. J Fr Ophtalmol (2009) 0.75

[Cyclin-dependent kinase inhibitory proteins in normal and transformed choroidal melanocytes]. J Fr Ophtalmol (1999) 0.75

The follicle-associated epithelium in the bursa of Fabricius cell origin studied by means of quail-chick chimeras and monoclonal antibodies. J Leukoc Biol (1986) 0.75

[Iris metastasis of a malignant sympathoblastoma in a newborn infant]. Bull Soc Ophtalmol Fr (1983) 0.75

[Survey of complications in Descemet stripping automated endothelial keratoplasty in 32 eyes]. J Fr Ophtalmol (2009) 0.75

Cytoadherence of lymphocytes from type I diabetic subjects to insulin-secreting cells. Marker of anti-beta-cell cellular immunity. Diabetes (1987) 0.75

[Maculopathy and chorioretinal paravascular atrophy]. Bull Soc Ophtalmol Fr (1983) 0.75

Class II MHC antigen induction on rat insulinoma (RINm5F) and colon carcinoma (TS) cells by co-culture with diabetic and normal xenogenic lymphocytes. J Autoimmun (1989) 0.75

[Peripheral retinal neovascularization in sarcoidosis. Apropos of a case]. Bull Soc Ophtalmol Fr (1984) 0.75

Oncoprotein fos activation in epithelial-cells induces an epitheliomesenchymal conversion and changes the receptor encoded by the fgfr-2 messenger-RNA from k-sam to bek. Oncol Rep (1995) 0.75

[The HLA system class II. Its implication in auto-immune endocrine diseases]. Ann Endocrinol (Paris) (1989) 0.75

In vitro relationship of CD4 cells from type I diabetic patients and xenogeneic beta-cell membranes. Diabetes (1989) 0.75

Annexin V-coated intraocular lenses. J Cataract Refract Surg (1996) 0.75

[Corneal transplantation of a corneal graft with radial keratotomy]. J Fr Ophtalmol (2006) 0.75